Treatment of Adolescent Suicide Attempters (TASA)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

June 30, 2007

Conditions
DepressionSuicide, Attempted
Interventions
DRUG

fluoxetine

DRUG

sertraline

DRUG

citalopram

DRUG

escitalopram

DRUG

bupropion

DRUG

mirtazapine

DRUG

venlafaxine

DRUG

lithium

BEHAVIORAL

Cognitive Behavioral Therapy

Trial Locations (6)

10016

New York University Child Study Center, New York

10032

Columbia University at the New York State Psychiatric Institute, New York

15213

University of Pittsburgh - Western Psychiatric Institute and Clinic, Pittsburgh

21287

Johns Hopkins University, Baltimore

27705

Duke University Medical Center, Durham

75235

University of Texas, Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00080158 - Treatment of Adolescent Suicide Attempters (TASA) | Biotech Hunter | Biotech Hunter